InterCure Ltd
intercure.coWhat Do They Do?
Produces and sells pharmaceutical-grade cannabis and cannabis-based products for medical use to patients, and operates pharmacies and trade houses that serve patients and pharmacies.
20-F for FY2025, filed Apr 30, 2026We (more specifically through Canndoc) are a pioneer in the production (including the breeding, cultivating and processing), manufacturing…View ↗
Through our subsidiaries, we operate the first and leading chain of private pharmacies focused on medical cannabis in Israel which includes…View ↗
Pharma Zone’s operations are focused on the management and operation of the Pharma Zone trade house which operates as a distributor of…View ↗
Who Are Their Customers?
Patients obtain products through licensed retail pharmacies, where they can fill prescriptions or arrange home delivery; InterCure also sells through pharmaceutical distributors and pharmacies.
20-F for FY2025, filed Apr 30, 2026Under current regulations, patients fill prescriptions directly from a registered pharmacy. Our products meet all of the IMCA standards and…View ↗
How Are They Changing?
Target markets
The latest report adds Australia to the company's stated target markets for distributing medical cannabis products; the older report named Israel and the European Union.
20-F for FY2022, filed May 1, 2023 20-F for FY2025, filed Apr 30, 2026We believe that our future growth is dependent upon our ability to further develop and commercialize our extensive know-how regarding the…View ↗
We believe that our future growth is dependent upon our ability to further develop and commercialize our extensive know-how regarding the…View ↗
Who Do They Compete With?
Competes with Aurora Cannabis, Canopy Growth, Seah Medical Group, Village farms Crop, and Bedrocan International
20-F for FY2025, filed Apr 30, 2026Within the pharmaceutical-grade cannabis industry, we currently compete directly with manufacturers in Israel, and global manufacturers…View ↗
Loading...
